PCN13 COST-BENEFIT ANALYSIS OF A 21-GENE RECURRENCE SCORE FOR EARLY STAGE BREAST CANCER IN SINGAPORE
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)73106-0
https://www.valueinhealthjournal.com/article/S1098-3015(11)73106-0/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
1265
First Page :
A512
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73106-0&doi=10.1016/S1098-3015(11)73106-0